Larry Patterson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Larry Patterson has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Abu Yusuf Ansari
Department of Data Science, University of Mississippi Medical Center, Jackson, MS 39216, USA
1 shared publication - Ali Mirza Onder
Division of Pediatric Nephrology, Le Bonheur Children's Hospital, University of Tennessee, School of Medicine, 49 N Dunlop Street, Faculty Office Building, Room 322, Memphis, TN, 38105, USA.
1 shared publication - Ayah Elmaghrabi
Division of Pediatric Nephrology, Children’s Medical Center Dallas, UT Southwestern, Dallas, TX 75235, USA
1 shared publication - Craig B. Langman
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
1 shared publication - Daniel Ranch
Division of Pediatric Nephrology, University of Texas Health Science Center, San Antonio, TX 78229, USA
1 shared publication - Diego H. Aviles
Affiliation: Department of Pediatric Nephrology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States of America
1 shared publication
Latest Publications
- Open Access
- 25 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4251
Persistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium Study
Our objective was to examine serum ferritin trends after conversion to permanent vascular access (PVA) among children who started hemodialysis (HD) using tunneled cuffed catheters (TCC). Retrospective chart reviews were completed on 98 subjects from 20 pediatric HD centers. Serum ferritin levels were collected at the creation of PVA and for two years thereafter. There were 11 (11%) arteriovenous grafts (AVG) and 87 (89%) arteriovenous fistulae (AVF). Their mean TCC use was 10.4 ± 17.3 months. Serum ferritin at PVA creation was elevated at 562.64 ± 492.34 ng/mL, increased to 753.84 ± 561.54 ng/mL (p = < 0.001) in the first year and remained at 759.60 ± 528.11 ng/mL in the second year (p = 0.004). The serum ferritin levels did not show a statistically significant linear association with respective serum hematocrit values. In a multiple linear regression model, there were three predictors of serum ferritin during the first year of follow-up: steroid-resistant nephrotic syndrome as primary etiology (p = 0.035), being from a center that enrolled >10 cases (p = 0.049) and baseline serum ferritin level (p = 0.017). Increasing serum ferritin after conversion to PVA is concerning. This increase is not associated with serum hematocrit trends. Future studies should investigate the correlation of serum transferrin saturation and ferritin levels in pediatric HD patients.
- 25 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4251
Open AccessPersistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium Study
Our objective was to examine serum ferritin trends after conversion to permanent vascular access (PVA) among children who started hemodialysis (HD) using tunneled cuffed catheters (TCC). Retrospective chart reviews were completed on 98 subjects from 20 pediatric HD centers. Serum ferritin levels were collected at the creation of PVA and for two years thereafter. There were 11 (11%) arteriovenous grafts (AVG) and 87 (89%) arteriovenous fistulae (AVF). Their mean TCC use was 10.4 ± 17.3 months. Serum ferritin at PVA creation was elevated at 562.64 ± 492.34 ng/mL, increased to 753.84 ± 561.54 ng/mL (p = < 0.001) in the first year and remained at 759.60 ± 528.11 ng/mL in the second year (p = 0.004). The serum ferritin levels did not show a statistically significant linear association with respective serum hematocrit values. In a multiple linear regression model, there were three predictors of serum ferritin during the first year of follow-up: steroid-resistant nephrotic syndrome as primary etiology (p = 0.035), being from a center that enrolled >10 cases (p = 0.049) and baseline serum ferritin level (p = 0.017). Increasing serum ferritin after conversion to PVA is concerning. This increase is not associated with serum hematocrit trends. Future studies should investigate the correlation of serum transferrin saturation and ferritin levels in pediatric HD patients.